Needham Downgrades Hims & Hers Stock (HIMS) on Fallout with Novo Nordisk. Wall Street Sees Legal Risks

tipranks.com/news/needham-downgrades-hims-hers-stock-hims-on-fallout-with-novo-nordisk-wall-street-sees-legal-risks

On Monday, Hims & Hers (HIMS) stock plunged about 35% after Danish drugmaker Novo Nordisk (NVO) ended its partnership with HIMS, accusing it of illegally selling copycats of its weight-loss drug Wegovy (semaglutide). In reaction, Needham analyst Ryan MacDonald downgraded Hims & Hers…

This story appeared on tipranks.com, 2025-06-24 15:07:29.050000.
The Entire Business World on a Single Page. Free to Use →